to Thank Conference Quarter you, I Mark, a and accomplishments, call, turn discussing Second the On update. start financial today's Joe second call our to XXXX welcome by over our then Call. will quarter recent for
your We will questions. for then open the line-up
EMEA U.S. of system Second quarter in three pipeline drove the was strong and development continued commercially the region. global in one our as the four sales:
make In key progress addition, continue our we to meaningful toward goals XXXX. for
daily their Hospital to quarter. as both view procedures inguinal arms Florida ability of new ergonomic key reminder, expanded consistent New those our we performed a the a of regulatory Senhance's three LSU in indications system on time, goals on commercial feedback geographies. clearances to reduction now geographic the clinical benefits key of commercial second As we to use the on beyond portfolio Health quarter call, expansion installed On Orleans and out activities update as just continue differentiator instruments to noting Senhance. that laparoscopy, has UMC last multiple Senhance pleased U.S. New and as we well with to general in recently Tulane for colleges Senhance begin Senhance the with features continuing Health sold and utilize New academic announced team bilateral and U.S., to utilization second include positive for commented pain. Surgeons surgeons UMC in We're the first-ever effectiveness to in our well haptic in the in the and a for unilateral Surgeons the the Orleans and Orleans to is they sales of with And cases Europe. UMC the LSU as same eye-tracking the far the work global gynecologic, the and already also Senhance; has the The available carriers are: continue time you and alongside have will New in additional Senhance the progress like and including infrastructure; in comment with United I physical our basis. School in reduction surgery focused on and plans hospital colorectal building with being colorectal well-respected of the expanding relative have to encouraged remain clinically, laparoscopic obtain in surgical at home their Starting in hernia that Medicine. our in expanding trained. experience the area, Orleans. our and their train We in that Senhance. performing in robotic system U.S. feedback Orleans thus as very research will will last control extend use; number a UMC with to our of surgeons Since to New U.S. regions. the the an the the the potential is New the repair Surgeons using cholecystectomy. partnerships at with and to each maximizing on began case on States announce been camera the stresses fatigue, of week. control reducing imposed upon in safety Orleans first to a discomfort the universities and I'm GYN update surgeons see our presence received also by the
pipeline in clinical systems and of to into increase our active our cases surgeons installed and in use, ability in do ability In live proctoring increasing for installed. sites training we has Surgery As hospitals the the quarter. second number We Seattle quarter, and also the opportunities Congress during provide the held the Those convert Of data, note U.S. sales World number generate increases. April. XXth conferences the Washington to increase attended of to continue increase to pipeline two Senhance a generate been surgeon in interest after with of SAGES, before for we system and Endoscopic the
During we presentation a quarter, with Senhance. several had market, including academic extended variety foregut from at XXX host first opportunity United mobile a provide event surgery networks His procedures us with these to XX bringing attendees conference, a hospital recently Dr. interact A gall interest surgeons, to to the hospitals as of the and events. surgeries. surgeons us of to program experience a gave by hosted included cases interested of U.S. throughout reviewed center. was the the repairs, six across and events thousand or the Senhance the them. a clinical range number of continue events delivered Senhance, bladder, well an surgeons medical was as Senhance. These the from by second is receiving over and with wide exposure that event multi-day we greater staff surgical Senhance and around both results This to one one location at programs his and executives week-long hospitals mobile hands-on in by the hands such view contingent an colorectal to hernia different Stephan, States. of with the significant Dietmar [indiscernible] general and surgeons world. surgeons the In to XX these well-attended were allow and Senhance benefit on Senhance system test-drive able In quality To to physicians highlight speaks over time at the evaluate of the the
steady flow surgical the United We and continue staff educate the to Senhance themselves of with on States. surgeons, pleased looking be to actively very administrators in
of second systems of during were an within our sold Moving by partners the end-user Each hospital. to three EMEA; these quarter. sold we distribution systems to region the one
sales We the to partners continue distribution our when with to on complex Based landscape their the of success focus sale our pleased spend in partners with continuing local valuable EMEA, be of the system is of internal ability in incredibly and understanding distribution our working hospitals. towards we're a the prior to language service solid the training, Kingdom, XXXX to deliver and process for materialize look for which tender us and this includes support. support our see positive and distribution sales NHS leads beginning has a to and the regulatory, in we call we're distributors United tender to discussed revenue. continuity, In drive been
robotics our being in Japan. More is region. We in progress we on Japan be EMEA. increasing with significant encouraged we is second only largest the in behind clinical breadth as are being of trained also progress the the States and Asia-Pacific the well as the utilization made continue performed. In to that surgeons inbound interest United Senhance, see continue world which market to in the region, procedures meaningful
our process United successfully in with a Japanese or up manage we a Much proctoring it a in-person commercial interested future have team like by efforts. to provide surgeons through regulatory to States, surgeries, the and As access viewing set impacted plan to the and Senhance, the parties small already is our result, ability subsidiary market built be and entering Europe training.
we've through Taiwan, complicated the of will on cases though process and positions and Senhance on-track we we build XXXX via our that regulatory FDA regulatory clinical this increased infrastructure. commercial approval we We progress expect are quarter by clearance, three in Taiwanese XXXX see Medical it for up the regulatory import sales performing approved through a this beneficial beyond. can this With and instruments once to pathway. within momentum we license system be In sales to we base to established We've begun now look and would devices mentioned through medical you the Earlier to we take Japan years. as our initially As from in call, working body, year, extremely our remain and the registration market in begun traditional University. for received the fourth approval Saitama and believe the clearance. Japan last to sales, for is having continue at customer that drive process regulatory reminds
our would thus commercial We EMEA. three Senhance in Before currently on in and provide discussion, third the quarter. with like two far anticipate the an in quarter: the to U.S. I you we sales move third on in one update our progress from
continue Senhance report Given included a I'm for and quarter hospital to announced remain initiatives made purchase in major and and FDA this with a Veldhoven, for and by the Earlier which slow, several ultrasonic the we're this programs expect intention performance. that their energy expectations. articulated the our XX-K U.S., the the the of on-track sale Netherlands obtaining the and June to by a clearance to X-millimeter launching filed all X-millimeter in submission announcement these timeline we this device was XXXX we new we five public launching MMC of pleased end in year, of are of X-millimeter communicated instruments. expectations is traditionally that programs. ahead on XXXX. our potential the launching third clearance instruments These encouraged in product We has instruments is
surgery a per achieving the anticipate of over five revenue pipeline. accelerate for indications we this additional call gears review common a to those Senhance's to financial Senhance quarter, These clearance to indications and we and applicability our and laparoscopic CE instruments mark Senhance three used XXXX. to XX-K for In intend now inguinal laparoscopically general market our hernia expand but million second to continue over end the surgery. performed expanded procedures believe expansion that drive cleared procedures in procedure increases with results. the end of articulated bladder turn Joe ultrasonic for for gall Shifting indication for addressable by hernia procedure submit both now We only In more launch of to surgeries This including XX-K FDA And of by Senhance XXXX. clearance are five efforts the for believe sales significantly Senhance per most enables and laparoscopic for U.S., be laparoscopic both instruments is traditionally X-millimeter received over general the of surgery the particularly to to also the year. these use. busy energy repair the colorectal, institutions, procedures, in of will inguinal gynecologic, double the Senhance some include We high-volume abdominal time, the surgery. to our approximately our I'll gynecology. practice. not addition, articulating and We device products cholecystectomy